Candela Corporation (NASDAQ: CLZR) announced today that its Vbeam(R) pulsed dye laser was featured on CBS's "The Early Show" on Wednesday, February 25th and Thursday, February 26th during a two-part birthmark treatment procedure series. Dr. Roy Geronemus of the Laser & Skin Surgery Center of New York, a leading surgeon in the treatment of birthmarks, demonstrated the Vbeam laser as a treatment option for the removal of birthmarks.

Each year, one in ten children is born with a vascular birthmark, commonly referred to as a "port wine stain." These birthmarks can range in color from pale pink to dark purple, and vary in size. Treatments for port wine stains have drastically improved in recent years with the advancement of laser technologies, such as the Vbeam from Candela.

Gerard E. Puorro, Candela's President and Chief Executive Officer, commented, "It's admirable that CBS and Hannah Storm decided to raise awareness about the treatment of port wine stains, as it is a topic not easily discussed. Now, many children and their parents can be better informed about the treatment options currently available for this condition."

About Vbeam:

Vbeam is a pulsed dye laser developed by Candela Corporation for the treatment of facial veins, rosacea, leg veins, port wine stains, scars, wrinkles, psoriasis, stretch marks, warts and acne.

About Candela:

Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 60 countries from offices in the United States, Europe, Japan and other Asian locations. Candela established the aesthetic laser market 15 years ago, and currently has an installed base of over 7,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer (Male/Female/Handicapped/Veteran). Visit Candela on the Web at http://www.candelalaser.com.

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Annual Report on Form 10-K for the year ended June 28, 2003 and subsequent Quarterly Reports on Form 10-Q. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.